LP
LKFT

LMR Partners’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

LMR Partners’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-283,400
Closed -$7.93M – 1525
2025
Q2 		$7.93M Buy
+283,400
New +$7.6M 0.06% 334

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LMR Partners's LKFT Position: Q1 2025 in Review

LMR Partners sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2025, closing a stake of 10,768 shares — an estimated $296K sold.

LMR Partners first reported a position in LKFT in Q3 2021 and held it in 12 quarters. The position peaked at $9.75M in Q4 2021. 83 funds tracked by Wall St. Rank hold LKFT as of Q1 2025.

  • LMR Partners reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2025 after selling out during the quarter.
  • LMR Partners sold 10,768 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2025, an estimated $296K.
  • LMR Partners first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2021 and held it in 12 quarters.
  • LMR Partners's Lakefront Biotherapeutics American Depositary Shares position peaked at $9.75M in Q4 2021.
  • 83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.